Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Fortrea Holdings Inc (FTRE)

Fortrea Holdings Inc (FTRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,769,781
  • Shares Outstanding, K 89,700
  • Annual Sales, $ 3,109 M
  • Annual Income, $ -3,400 K
  • EBIT $ -6 M
  • EBITDA $ 90 M
  • 60-Month Beta 0.70
  • Price/Sales 0.56
  • Price/Cash Flow 7.84
  • Price/Book 1.15

Options Overview Details

View History
  • Implied Volatility 61.51% ( +2.65%)
  • Historical Volatility 91.40%
  • IV Percentile 72%
  • IV Rank 36.85%
  • IV High 116.66% on 11/04/24
  • IV Low 29.32% on 11/24/23
  • Put/Call Vol Ratio 7.14
  • Today's Volume 2,286
  • Volume Avg (30-Day) 695
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 7,109
  • Open Int (30-Day) 9,915

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.36
  • Number of Estimates 4
  • High Estimate 0.40
  • Low Estimate 0.31
  • Prior Year 0.19
  • Growth Rate Est. (year over year) +89.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.53 +19.36%
on 10/31/24
25.28 -21.95%
on 11/11/24
+1.93 (+10.84%)
since 10/22/24
3-Month
16.53 +19.36%
on 10/31/24
25.28 -21.95%
on 11/11/24
-1.68 (-7.85%)
since 08/22/24
52-Week
16.53 +19.36%
on 10/31/24
41.02 -51.90%
on 03/21/24
-13.12 (-39.94%)
since 11/22/23

Most Recent Stories

More News
Fortrea Reports Third Quarter 2024 Results

FTRE : 19.73 (+1.18%)
Fortrea Releases Inaugural Corporate Social Responsibility Report

FTRE : 19.73 (+1.18%)
Fortrea Announces Date for Third Quarter 2024 Financial Results and Conference Call

FTRE : 19.73 (+1.18%)
Do Options Traders Know Something About Fortrea Holdings (FTRE) Stock We Don't?

Investors in Fortrea Holdings Inc. FTRE need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 20, 2024 $42.50 Put had some of the highest implied...

FTRE : 19.73 (+1.18%)
Why Fortrea Holdings Stock Climbed Nearly 10% Higher Today

The company's first quarter as a separate entity was better than anticipated.

LH : 239.67 (-0.21%)
FTRE : 19.73 (+1.18%)
Why Fortrea Holdings Stock Is Sinking Today

The contract research organization's first quarterly update as a stand-alone entity disappointed investors.

FTRE : 19.73 (+1.18%)
Why Shares of Labcorp Dropped Monday

The company completed the spinoff of contract research organization Fortrea Holdings.

LH : 239.67 (-0.21%)
FTRE : 19.73 (+1.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Fortrea Holdings Inc. is a provider of clinical development and patient access solutions to the life sciences industry. It provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services. Fortrea Holdings Inc. is based...

See More

Key Turning Points

3rd Resistance Point 21.15
2nd Resistance Point 20.64
1st Resistance Point 20.19
Last Price 19.73
1st Support Level 19.23
2nd Support Level 18.72
3rd Support Level 18.27

See More

52-Week High 41.02
Fibonacci 61.8% 31.66
Fibonacci 50% 28.78
Fibonacci 38.2% 25.89
Last Price 19.73
52-Week Low 16.53

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar